FDA Drug Application (010996) for DARVON COMPOUND-65 by XANODYNE PHARM

Back to FDA Applications sponsored by XANODYNE PHARM

Application Number010996
Product Number007
FormCAPSULE;ORAL
Dosage389MG;32.4MG;65MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDARVON COMPOUND-65
Active IngredientASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ASPIRIN60
List of drugs with Active Ingredient CAFFEINE44
List of drugs with Active Ingredient PROPOXYPHENE HYDROCHLORIDE17


Back to FDA Applications sponsored by XANODYNE PHARM